Cytoprotective effect of bismuth subsalicylate in indomethacin-treated rats is associated with enhanced mucus bismuth concentration

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 605-612

  Tanaka, S ^c   Guth, P H ^c   Carryl, O R ^a   Kaunitz, J D ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; BISMUTH SALICYLATE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE BISMUTH CITRATE; SALICYLATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PH; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG MIXTURE; HELICOBACTER PYLORI; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH MUCOSA LESION; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030838577     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00170.x     Document Type: Article

References (34)

1. Goldenberg MM, Honkomp LJ, Castellion AW. Prevention by bismuth subsalicylate of gastric mucosal lesions in response to noxious stimuli in rats. Pharm Res Commun 1978; 10: 13-20.
2. Goldenberg MM, Honkomp LJ, Burrous SE, Castellon AW. Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats. Gastroenterology 1975; 69: 636-40.
3. Konturek SJ, Kwiecien N, Obtulowicz W, Hebzda Z, Oleksy J. Effects of colloidal bismuth subcitrate on aspirin-induced gastric microbleeding, DNA loss, and prostaglandin formation in humans. Scand J Gastroenterol 1988; 23: 861-6.
4. Stables R, Campbell CJ, Clayton NM, et al. Gastric anti-secretory, mucosal protective, anti-pepsin, and anti-Helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993; 7: 237-46.
5. Hudson N, Murray FE, Cole AT, Turnbull GM, Lettis GM, Hawkey CJ. Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury. Aliment Pharmacol Ther 1993; 7: 515-21.
6. Lee SP. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid. Scand J Gastroenterol 1982; 17(Suppl. 80): 17-21.
7. Koo J, Ho J, Lam SK, Wong J, Ong GB. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Gastroenterology 1982; 82: 864-70.
8. Konturek SJ, Bilski J, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J. De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism. Gut 1987; 28(12): 1557-63.
9. Mertz-Nielsen A, Steenberg P, Neumark T, Bukhave K, Kask-Madsen J. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2. Aliment Pharmacol Ther 1991; 5(2): 127-53.
10. Slomiany BL, Nishikawa H, Bilski J, Slomiany A. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Am J Gastroenterol 1990; 85(4): 390-3.
11. Tay HP, Chaparala RC, Harmon JW, et al. Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits. Gut 1990; 31: 11-6.
12. Manhart MD. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Rev Infect Dis 1990; 12(Suppl. 1): S11-5.
13. Tanaka S, Guth PH, Paulsen G, Kaunitz JD. Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats. Gut 1996; 39: 164-71.
14. Kaneko K, Guth PH, Kaunitz JD. In vivo measurement of rat gastric surface cell intracellular pH. Am J Physiol 1991; 261: G548-52.
15. Kaneko K, Guth PH, Kaunitz JD, Na+/H+ exchange regulates intracellular pH of rat gastric cells in vivo. Pflug Arch 1992; 421: 322-8.
16. Kaunitz JD, Nishizaki Y, Kaneko K, Guth PH. Effect of orogastric nicotine on rat gastric mucosal gel thickness, surface cell viability, and intracellular pH. J Pharm Exp Ther 1993; 265: 948-54.
17. Nishizaki Y, Guth PH, Kaunitz JD. Isoproterenol enhances rat gastric mucosal barrier function in vivo. Gastroenterology 1993; 105: 340-6.
18. 2a. Gastroenterology 1979; 76: 497-503.
19. Sandzen B, Blom H, Dahlgren S. Gastric mucus gel layer thickness measured by direct light microscopy. An experimental study in the rat. Scand J Gastroenterol 1988; 23: 1160-4.
20. Price KJ, Hanson PJ, Whittle BJ. Stimulation by carbachol of mucus gel thickness in rat stomach involves nitric oxide. Eur J Pharmacol 1994; 263: 199-202.
21. 2 and carbenoxolone. Gastroenterology 1981; 80: 770-5.
22. Slikkerveer A, Helmich RB, de Wolff FA. Analysis for bismuth in tissue by electrothermal atomic absorption spectrometry. Clin Chem 1993; 39(5): 800-3.
23. Nishizaki Y, Guth PH, Kim G, Wayland H, Kaunitz JD. Pentagastrin enhances gastric mucosal defenses in vivo: luminal acid-dependent and independent effects. Am J Physiol 1994; 267: G94-104.
24. 2 release by central TRH in rats. Am J Physiol 1993; 264: G231-6.
25. Yoneda M, Taché Y. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats. Gastroenterology 1992; 102: 1568-74.
26. Mersereau WA, Hinchey EJ. Relationship between the gastric myoelectric and mechanical activity in the genesis of ulcers in indomethacin-insulin-treated rats. Dig Dis Sci 1988; 33(2): 200-8.
27. Ueki S, Takeuchi K, Okabe S. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 1988; 33(2): 209-16.
28. Crowther RS, Marriott C, James SL. Cation induced changes in the rheological properties of purified mucus glycoproteins. Biorheology 1984; 21: 253-63.
29. + ion and albumin. Mod Probl Pediatr 1976; 19: 54-65.
30. Marriot C, Shih CK, Litt M. Changes in the gel properties of tracheal mucus induced by divalent cations. Biorheology 1979; 16: 331-7.
31. Takeuchi K, Ueshima K, Hironaka Y, Fujioka Y, Matsumoto J, Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Digestion 1991; 49: 175-84.
32. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986; 31: 1114-22.
33. Lambert JR, King RG, Way DJ, et al. Accumulation of bismuth in gastric mucosa after De-Nol therapy - fact or fiction. Gastroenterology 1989; 96: A284(Abstract).
34. Lambert JR, Way DJ, King RG, et al. De-Nol vs. Pepto-Bismol - bismuth pharmacokinetics in the human gastric mucosa. Gastroenterology 1989; 96: A284(Abstract).